Results
|
|
11541.
|
|
|
|
11542.
|
|
|
|
11543.
|
|
|
|
11544.
|
|
|
|
11545.
|
|
|
|
11546.
|
Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients. [electronic resource] by
- Huang, Qiong
- Yin, Ji-Ye
- Dai, Xing-Ping
- Wu, Jing
- Chen, Xiang
- Deng, Cai-Shu
- Yu, Min
- Gong, Zhi-Cheng
- Zhou, Hong-Hao
- Liu, Zhao-Qian
Producer: 20110301
In:
European journal of clinical pharmacology vol. 66
Availability: No items available.
|
|
|
11547.
|
Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stress. [electronic resource] by
- Bedse, Gaurav
- Romano, Adele
- Tempesta, Bianca
- Lavecchia, Michele A
- Pace, Lorenzo
- Bellomo, Antonello
- Duranti, Andrea
- Micioni Di Bonaventura, Maria Vittoria
- Cifani, Carlo
- Cassano, Tommaso
- Gaetani, Silvana
Producer: 20151125
In:
Journal of neuroscience research vol. 93
Availability: No items available.
|
|
|
11548.
|
|
|
|
11549.
|
Daclatasvir combined with peginterferon alfa-2a and ribavirin in Japanese patients infected with hepatitis C genotype 1. [electronic resource] by
- Izumi, Namiki
- Yokosuka, Osamu
- Kawada, Norifumi
- Osaki, Yukio
- Yamamoto, Kazuhide
- Sata, Michio
- Ishikawa, Hiroki
- Ueki, Tomoko
- Hu, Wenhua
- McPhee, Fiona
- Hughes, Eric A
- Kumada, Hiromitsu
Producer: 20150708
In:
Antiviral therapy vol. 19
Availability: No items available.
|
|
|
11550.
|
|
|
|
11551.
|
The pharmacokinetics of daclatasvir and asunaprevir administered in combination in studies in healthy subjects and patients infected with hepatitis C virus. [electronic resource] by
- Eley, Timothy
- Sevinsky, Heather
- Huang, Shu-Pang
- He, Bing
- Zhu, Kurt
- Kandoussi, Hamza
- Gardiner, David
- Grasela, Dennis M
- Bertz, Richard
- Bifano, Marc
Producer: 20150511
In:
Clinical drug investigation vol. 34
Availability: No items available.
|
|
|
11552.
|
|
|
|
11553.
|
|
|
|
11554.
|
Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis. [electronic resource] by
- Asselah, Tarik
- Bourgeois, Stefan
- Pianko, Stephen
- Zeuzem, Stefan
- Sulkowski, Mark
- Foster, Graham R
- Han, Lingling
- McNally, John
- Osinusi, Anu
- Brainard, Diana M
- Subramanian, G Mani
- Gane, Edward J
- Feld, Jordan J
- Mangia, Alessandra
Producer: 20181231
In:
Liver international : official journal of the International Association for the Study of the Liver vol. 38
Availability: No items available.
|
|
|
11555.
|
|
|
|
11556.
|
|
|
|
11557.
|
Time to viral suppression is not related to achievement of SVR12 in HCV GT1-infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin. [electronic resource] by
- Alqahtani, S
- Ozaras, R
- Isakov, V
- Wyles, D
- Ferenci, P
- Feld, J J
- Calinas, F
- Gschwantler, M
- Gane, E
- Crawford, D
- Jacobson, I M
- Dumas, E O
- King, M
- Sulkowski, M
Producer: 20171101
In:
Journal of viral hepatitis vol. 24
Availability: No items available.
|
|
|
11558.
|
|
|
|
11559.
|
|
|
|
11560.
|
|